This is such exciting news!
The fund is also supporting two postgraduate researchers, one Master of Science (MSc) and one PhD researcher. If you are interested in applying, please look out for the adverts which are coming soon @UniOfYork@HullYorkMed
https://t.co/QH7eNrodFy
I'm thrilled to share that Dame Judi Dench has been made patron of the Yorkshire Macular Degeneration Fund, supporting valuable research into understanding the disease, early detection and better treatment.
@UniOfYork@HullYorkMed@EyeResearchYork
https://t.co/ctgmXfs2mq
Interested in a #PhD in #MacularDegeneration#research??? There are currently 6 scholarships available at the #YorkGraduateSchoolBoard for the 2024/25 academic year. Click the link below to find out more!!!
https://t.co/X5uUXjQ4TF
We're just 1 week away from the Yorkshire Retina Society #YRS 2023 winter meeting - don't forget to click the link below to register your place!!! #AMD#Uveitis#VisionResearch
Did you know that the Yorkshire Retina Society #YRS winter meeting is taking place in #York at the Principal Hotel on 8th December?? With only 3 weeks to go, check out the amazing program and register your place!! #AMD#Uveitis#VisionResearch
https://t.co/8xZOjtXB4K
Did you know that the Yorkshire Retina Society #YRS winter meeting is taking place in #York at the Principal Hotel on 8th December?? With only 3 weeks to go, check out the amazing program and register your place!! #AMD#Uveitis#VisionResearch
https://t.co/8xZOjtXB4K
Who's joining us @EURETINA 2023??
We're excited to share a number of results from our #MATE study by @ArchanaKaranth and new quality-of-life changes in #MATE by Mr Ahmed Saad plus our forthcoming #FASBAT study by Prof Gale @Richard00064290!
We look forward to seeing you there!!
Excited to share the first manuscript from the MATE pilot study by @ArchanaKaranth and Prof. Gale @Richard00064290@YSTeachingNHS - than you to all patients, clinicians and researchers involved in this study!!
https://t.co/2xnlYNE1kR
Lastly..... a preprint of the PRECISE study: A multi-modal AI-driven cohort selection tool based on response to loading-phase aflibercept for neovascular age-related macular degeneration #nAMD#wetAMD
https://t.co/1SVqkB4Sjg